Back

Mitochondrial players as novel therapeutic options in arrhythmogenic cardiomyopathy

12 April 2024 (08:30 - 17:30)
Organised by: Logo
Congress Presentation Part of: Poster session 1 Mitochondria CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Mrs Chiara Volani

Medical University of Innsbruck, Innsbruck (Austria)

68 More presentations in this session

Presentation thumbnail
Stage specific effects of insulin and Wnt on cell fate decisions in human induced pluripotent stem cell-derived cardiomyocytes
Assistant Professor J. Buikema (Amsterdam, NL)
Abstract
Presentation thumbnail
Role of NLRP3 inflammasome in cardiac damage in the setting of an acute cardiorenal syndrome
Ms L. Gonzalez-Lafuente (Madrid, ES)
Abstract
Presentation thumbnail
Altered firing activity of intracardiac neurons isolated from mice carrying the Scn5a-1798insD mutation
Doctor S. Casini (Amsterdam, NL)
Abstract
Presentation thumbnail
Adeno-associated virus (AAV) 6 provides efficient gene transfer upon intramyocardial injection in vivo
Mr J. Wang (Amsterdam, NL)
Abstract
Presentation thumbnail
Cardioprotective effects of Empagliflozin in cardiac volume overload-induced by aortocaval fistula in rats
Doctor M. Sykora (Bratislava, SK)
Abstract

Access the full session

Session thumbnail
Poster session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Alterations in oxidative phosphorylation complexes in arrhythmogenic cardiomyopathy using desmosomal KO cell model
13 April 2024
thumbnail
Congress Presentation
A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
26 August 2022
thumbnail
Congress Presentation
The new mechanism of apatinib in treating gastric cancer-related hypertension: dynamin-related protein 1-mediated pathological mitochondrial fission in endothelial cells
1 September 2025
thumbnail
Congress Presentation
In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources